AMGN vs. ZBH: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at AMGN and ZBH, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
AMGN dominates in value with a market cap of 145.90 billion USD, eclipsing ZBH’s 18.35 billion USD by roughly 7.95×.
ZBH carries a higher beta at 0.78, indicating it’s more sensitive to market moves, while AMGN remains steadier at 0.50.
| Symbol | AMGN | ZBH |
|---|---|---|
| Company Name | Amgen Inc. | Zimmer Biomet Holdings, Inc. |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Medical - Devices |
| CEO | Mr. Robert A. Bradway | Mr. Ivan Tornos |
| Price | 271.34 USD | 92.74 USD |
| Market Cap | 145.90 billion USD | 18.35 billion USD |
| Beta | 0.50 | 0.78 |
| Exchange | NASDAQ | NYSE |
| IPO Date | June 17, 1983 | July 25, 2001 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of AMGN and ZBH over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
For a detailed comparison of valuation metrics between AMGN and ZBH, please refer to the table below.
| Symbol | AMGN | ZBH |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 24.60 | 25.75 |
| Forward PEG Ratio (TTM) | 7.08 | 3.45 |
| Price-to-Sales Ratio (P/S, TTM) | 4.28 | 2.38 |
| Price-to-Book Ratio (P/B, TTM) | 23.52 | 1.35 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 13.37 | 12.77 |
| EV-to-EBITDA (TTM) | 15.71 | 13.49 |
| EV-to-Sales (TTM) | 5.70 | 3.14 |
| EV-to-Free Cash Flow (TTM) | 17.82 | 16.80 |
Dividend Comparison
AMGN’s dividend yield of 3.41% is about 230% higher than ZBH’s 1.04%, underscoring its stronger focus on returning cash to shareholders.
| Symbol | AMGN | ZBH |
|---|---|---|
| Dividend Yield (TTM) | 3.41% | 1.04% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of AMGN and ZBH, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- AMGN is heavily leveraged (debt-to-equity ratio 9.24), which can boost returns but raises risk if borrowing costs climb, while ZBH at 0.52 keeps leverage at a more moderate level.
| Symbol | AMGN | ZBH |
|---|---|---|
| Current Ratio (TTM) | 1.17 | 3.30 |
| Quick Ratio (TTM) | 0.88 | 1.97 |
| Debt-to-Equity Ratio (TTM) | 9.24 | 0.52 |
| Debt-to-Assets Ratio (TTM) | 0.64 | 0.32 |
| Interest Coverage Ratio (TTM) | 3.19 | 6.00 |